Your browser doesn't support javascript.
loading
Cannabis vaporisation: Understanding products, devices and risks.
MacCallum, Caroline A; Lo, Lindsay A; Pistawka, Carly A; Christiansen, April; Boivin, Michael.
Afiliação
  • MacCallum CA; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Lo LA; Department of Public Health Science, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Pistawka CA; Faculty of Science, University of British Columbia, Vancouver, Canada.
  • Christiansen A; Six Degrees Medical, Vancouver, Canada.
  • Boivin M; CommPharm Consulting, Barrie, Canada.
Drug Alcohol Rev ; 43(3): 732-745, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38124429
ABSTRACT
ISSUES Vaporisation is a common method of cannabis administration. Inconsistent terminology and jargon regarding vaporisation has led to confusion. The increasing public interest and access to cannabis, combined with possible safety concerns associated with certain cannabis vaping products, warrants improved consumer and public and health care professional knowledge.

APPROACH:

To improve this knowledge, we conducted a review of the common terminology, regulatory status, products and device types related to cannabis vaporisation. KEY

FINDINGS:

Cannabis vaporisation devices can be separated into nine types. While vaporisation reduces respiratory risks associated with cannabis combustion, not all vaping products and device types carry the same level of safety. Metered dose inhalers and dried product vaporisers present the lowest safety risk due to a lower risk of toxin exposure and the use of lower tetrahydrocannabinol potency products. IMPLICATIONS As both vaping and cannabis use increase in popularity, focusing on accurate health education will help facilitate health promotion to encourage lower risk use. The current lack of understanding on risk differences between types of cannabis vaporisation is a missed opportunity for harm reduction. Increased opportunities for public health and health care professional education on different cannabis vaporisation devices and associated risks are warranted. Improvements to health warning labelling may also be beneficial.

CONCLUSION:

Not all cannabis vaporisation devices and products carry the same level of risk. A better understanding of risk differentiation is needed among consumers and health professionals. Continued research, policy development and health education can lead to safer cannabis vaporisation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cannabis / Alucinógenos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cannabis / Alucinógenos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article